JP2014530350A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530350A5 JP2014530350A5 JP2014530362A JP2014530362A JP2014530350A5 JP 2014530350 A5 JP2014530350 A5 JP 2014530350A5 JP 2014530362 A JP2014530362 A JP 2014530362A JP 2014530362 A JP2014530362 A JP 2014530362A JP 2014530350 A5 JP2014530350 A5 JP 2014530350A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- biomarker
- group
- nephrotoxicity
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161534402P | 2011-09-14 | 2011-09-14 | |
| EP11181219.4 | 2011-09-14 | ||
| EP11181219 | 2011-09-14 | ||
| US61/534,402 | 2011-09-14 | ||
| EP11187016.8 | 2011-10-28 | ||
| EP11187016 | 2011-10-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014530350A JP2014530350A (ja) | 2014-11-17 |
| JP2014530350A5 true JP2014530350A5 (enExample) | 2015-11-05 |
Family
ID=47882695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014530362A Pending JP2014530350A (ja) | 2011-09-14 | 2012-09-14 | 腎臓毒性を評価するための手段及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20150011423A1 (enExample) |
| EP (1) | EP2756304A4 (enExample) |
| JP (1) | JP2014530350A (enExample) |
| KR (1) | KR20140074293A (enExample) |
| CN (2) | CN106018783A (enExample) |
| CA (1) | CA2845117A1 (enExample) |
| IL (1) | IL230937A0 (enExample) |
| WO (1) | WO2013038369A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6595984B2 (ja) * | 2013-05-14 | 2019-10-23 | メタボロン，インコーポレイテッド | 腎機能に関連付けられるバイオマーカーおよびそれを使用する方法 |
| CN104614291B (zh) * | 2015-01-13 | 2018-01-16 | 江苏普瑞姆纳米科技有限公司 | 评估大气细颗粒物暴露对生物体毒性作用的标志物和方法 |
| CN107422062B (zh) * | 2017-05-26 | 2019-06-25 | 广东产品质量监督检验研究院 | 一种同时测定保健食品中苯溴马隆、别嘌醇和丙磺舒含量的方法 |
| CN107589200B (zh) * | 2017-09-15 | 2020-06-16 | 山东省科学院生物研究所 | 一种利用诊断标志物评价微量外源化学物早期毒性的方法及其应用 |
| CN108426956B (zh) * | 2018-04-13 | 2020-10-09 | 郑州泰丰制药有限公司 | 一种高效液相色谱法测定卡托普利片中杂质f的方法 |
| EP3857234A1 (en) * | 2018-09-29 | 2021-08-04 | Numares AG | Biomarkers for precisely predicting the glomerular filtration rate and for indicating pathophysiologic factors of an impaired glomerular filtration rate |
| CN115469026B (zh) * | 2022-07-14 | 2023-10-20 | 中日友好医院(中日友好临床医学研究所) | 用于检测环孢素a肾毒性相关标志物的检测试剂、试剂盒及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ037799A0 (en) * | 1999-05-14 | 1999-06-10 | Vri Biomedical Pty Ltd | Methods for diagnosing and/or predicting the risk of gastric cancer |
| CA2447357A1 (en) * | 2001-05-22 | 2002-11-28 | Gene Logic, Inc. | Molecular toxicology modeling |
| GB0215509D0 (en) * | 2002-07-04 | 2002-08-14 | Novartis Ag | Marker genes |
| US20050272101A1 (en) * | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
| WO2007028636A1 (en) * | 2005-09-09 | 2007-03-15 | Medizinische Universität Innsbruck | Method for predicting the progression of chronic kidney disease by measuring apolipoprotein a-iv |
| WO2007112906A1 (en) * | 2006-04-05 | 2007-10-11 | F. Hoffmann-La Roche Ag | Biomarker for farnesyl pathway |
| US20100068251A1 (en) * | 2006-10-10 | 2010-03-18 | Jina Pharmaceuticals, Inc. | Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof |
| US20090220982A1 (en) * | 2008-02-29 | 2009-09-03 | Achaogen Inc.. | Compositions and methods for determining nephrotoxicity |
| CA2724422A1 (en) * | 2008-05-28 | 2009-12-23 | Basf Se | Means and methods for assessing increased peroxisomal proliferation |
| WO2009153136A2 (en) * | 2008-05-28 | 2009-12-23 | Basf Se | Means and methods for assessing liver toxicity |
| EP2438441B1 (en) * | 2009-06-02 | 2014-05-21 | BIOCRATES Life Sciences AG | New biomarkers for assessing kidney diseases |
-
2012
- 2012-09-14 CN CN201610451174.9A patent/CN106018783A/zh active Pending
- 2012-09-14 CA CA2845117A patent/CA2845117A1/en not_active Abandoned
- 2012-09-14 JP JP2014530362A patent/JP2014530350A/ja active Pending
- 2012-09-14 WO PCT/IB2012/054790 patent/WO2013038369A1/en not_active Ceased
- 2012-09-14 KR KR1020147006458A patent/KR20140074293A/ko not_active Withdrawn
- 2012-09-14 CN CN201280044868.0A patent/CN103814295B/zh not_active Expired - Fee Related
- 2012-09-14 US US14/344,277 patent/US20150011423A1/en not_active Abandoned
- 2012-09-14 EP EP12831825.0A patent/EP2756304A4/en not_active Withdrawn
-
2014
- 2014-02-12 IL IL230937A patent/IL230937A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530350A5 (enExample) | ||
| Di Minno et al. | Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies | |
| Lazzarino et al. | Serum compounds of energy metabolism impairment are related to disability, disease course and neuroimaging in multiple sclerosis | |
| JP2007033132A5 (enExample) | ||
| EP3156925A3 (en) | Copd biomarker signatures | |
| WO2010057184A3 (en) | Methods for detection of acute kidney injury in humans | |
| HRP20130127T1 (hr) | Prediktivni biomarkeri bubrežne sigurnosti i potpisi biomarkera za praä†enje funkcije bubrega | |
| RU2016137685A (ru) | Способ диагностики туберкулеза | |
| BRPI0419002A (pt) | método para detectar e para diferenciação entre adenoma colorretal e/ou carcinoma colorretal, método para monitoramento do curso de adenoma colorretal, uso de transtirretina como biomarcador, sistema de teste, arranjo compreendendo moléculas de detecção | |
| BR112018073178A2 (pt) | método, matriz e uso dos mesmos | |
| BR112014005651A2 (pt) | aparelho de diagnóstico | |
| JP2020514689A5 (enExample) | ||
| WO2015031676A3 (en) | Integrity testing of hair samples | |
| Karim et al. | Elevated plasma CAF22 are incompletely restored six months after COVID-19 infection in older men | |
| JP2018536170A5 (enExample) | ||
| EP2585832A4 (en) | REDUCTION OF INCORRECT RESULTS OF TEST MEASUREMENTS | |
| WO2022190036A3 (en) | Methods for predicting treatment response in ulcerative colitis | |
| Liang et al. | Effect of sensor number and distribution on accuracy rate of wood defect detection with stress wave tomography | |
| BR112014027490A2 (pt) | método de detecção eletroquímica | |
| JP2018533002A (ja) | 微生物を検出するためのバイオセンサおよび方法 | |
| JP2017083340A5 (enExample) | ||
| CA2991055A1 (en) | Diagnostic test for alzheimer's disease based on identification of a proteolytic pathway | |
| JP2014526681A5 (enExample) | ||
| Sabour | Interlaboratory and interstudy reproducibility of a novel lateral-flow device: a statistical issue | |
| Abbate et al. | Evaluation of an automated extraction system in combination with Affigene® CMV Trender for CMV DNA quantitative determination: comparison with nested PCR and pp65 antigen test |